Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Anhui Sunhere Pharmaceutical Excipients Co Ltd (300452) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.48 Million ≈ $4.17 Million USD) by net assets (CN¥1.03 Billion ≈ $151.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Anhui Sunhere Pharmaceutical Excipients liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Anhui Sunhere Pharmaceutical Excipients Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Anhui Sunhere Pharmaceutical Excipients Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Anhui Sunhere Pharmaceutical Excipients Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Sunhere Pharmaceutical Excipients Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Costamare Bulkers Holdings Limited NYSE:CMDB	0.034x
Sagimet Biosciences Inc. Series A Common Stock NASDAQ:SGMT	-0.084x
Shenzhen Sunyes Electronic Manufacturing Holding Co Ltd SHE:002388	-0.066x
Aurora Corp TW:2373	-0.013x
Key Ware Electronics Co Ltd TWO:5498	0.032x
Wuhan Nusun Landscape Co Ltd SHE:300536	0.000x
Gladstone Capital Corporation NASDAQ:GLAD	0.029x
Cross Country Healthcare Inc NASDAQ:CCRN	0.015x

Annual Cash Flow Conversion Efficiency for Anhui Sunhere Pharmaceutical Excipients Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Anhui Sunhere Pharmaceutical Excipients Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 300452 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.07 Billion ≈ $157.12 Million	CN¥191.99 Million ≈ $28.09 Million	0.179x	+47.38%
2024-12-31	CN¥975.30 Million ≈ $142.72 Million	CN¥118.33 Million ≈ $17.32 Million	0.121x	-20.56%
2023-12-31	CN¥935.25 Million ≈ $136.86 Million	CN¥142.84 Million ≈ $20.90 Million	0.153x	-9.32%
2022-12-31	CN¥788.62 Million ≈ $115.40 Million	CN¥132.82 Million ≈ $19.44 Million	0.168x	+14.51%
2021-12-31	CN¥705.92 Million ≈ $103.30 Million	CN¥103.82 Million ≈ $15.19 Million	0.147x	+12.63%
2020-12-31	CN¥655.17 Million ≈ $95.87 Million	CN¥85.55 Million ≈ $12.52 Million	0.131x	-1.98%
2019-12-31	CN¥596.57 Million ≈ $87.30 Million	CN¥79.47 Million ≈ $11.63 Million	0.133x	-0.59%
2018-12-31	CN¥557.89 Million ≈ $81.64 Million	CN¥74.76 Million ≈ $10.94 Million	0.134x	+5.55%
2017-12-31	CN¥500.23 Million ≈ $73.20 Million	CN¥63.51 Million ≈ $9.29 Million	0.127x	-7.60%
2016-12-31	CN¥402.70 Million ≈ $58.93 Million	CN¥55.33 Million ≈ $8.10 Million	0.137x	+16.99%
2015-12-31	CN¥363.20 Million ≈ $53.15 Million	CN¥42.66 Million ≈ $6.24 Million	0.117x	-43.49%
2014-12-31	CN¥177.20 Million ≈ $25.93 Million	CN¥36.83 Million ≈ $5.39 Million	0.208x	+19.79%
2013-12-31	CN¥149.23 Million ≈ $21.84 Million	CN¥25.89 Million ≈ $3.79 Million	0.173x	-20.42%
2012-12-31	CN¥121.17 Million ≈ $17.73 Million	CN¥26.41 Million ≈ $3.87 Million	0.218x	--

About Anhui Sunhere Pharmaceutical Excipients Co Ltd

SHE:300452 China Drug Manufacturers - Specialty & Generic

Market Cap

$408.61 Million

CN¥2.79 Billion CNY

Market Cap Rank

#13431 Global

#4013 in China

Share Price

CN¥11.91

Change (1 day)

+0.85%

52-Week Range

CN¥11.81 - CN¥16.85

All Time High

CN¥25.06